Evaluating Augmented Depression Therapy (ADepT): study protocol for a pilot randomised controlled trial.

ABSTRACT:

Background

While existing psychological treatments for depression are effective for many, a significant proportion of depressed individuals do not respond to current approaches and few remain well over the long-term. Anhedonia (a loss of interest or pleasure) is a core symptom of depression which predicts a poor prognosis but has been neglected by existing treatments. Augmented Depression Therapy (ADepT) has been co-designed with service users to better target anhedonia alongside other features of depression. This mixed methods pilot trial aims to establish proof of concept for ADepT and to examine the feasibility and acceptability of a future definitive trial evaluating the clinical and cost-effectiveness of ADepT, compared to an evidence-based mainstream therapy (Cognitive Behavi

SUBMITTER: Dunn BD 

PROVIDER: S-EPMC6486988 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature